Variant report
Variant | nsv438069 |
---|---|
Chromosome Location | chr8:91183774-91186718 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:10)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:10 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr8:91185841..91188123-chr8:91204110..91206951,2 | MCF-7 | breast: | |
2 | chr8:91179420..91181498-chr8:91184208..91186525,2 | MCF-7 | breast: | |
3 | chr8:91177198..91178801-chr8:91185940..91187719,2 | MCF-7 | breast: | |
4 | chr8:91184470..91187262-chr8:91242748..91244864,2 | K562 | blood: | |
5 | chr8:91180611..91183081-chr8:91185061..91187294,2 | K562 | blood: | |
6 | chr8:91182635..91184941-chr8:91189567..91191174,2 | MCF-7 | breast: | |
7 | chr8:91185537..91188064-chr8:91252722..91255551,2 | K562 | blood: | |
8 | chr8:91186436..91188660-chr8:91289229..91291075,2 | K562 | blood: | |
9 | chr8:91183433..91185602-chr8:91248218..91250005,2 | K562 | blood: | |
10 | chr8:91175219..91178633-chr8:91184019..91187268,3 | K562 | blood: |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs4961177 | chr8:91183774-91183775 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
2 | rs563232810 | chr8:91183786-91183787 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs577210856 | chr8:91183818-91183819 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs192592837 | chr8:91183820-91183821 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs145230111 | chr8:91183841-91183842 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs568906508 | chr8:91183878-91183879 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs79720351 | chr8:91183880-91183881 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs560069319 | chr8:91183938-91183939 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs549075904 | chr8:91183952-91183953 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs537900938 | chr8:91183958-91183959 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs527456267 | chr8:91184006-91184007 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs548923030 | chr8:91184020-91184021 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs560889102 | chr8:91184029-91184030 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs184725380 | chr8:91184072-91184073 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs112375794 | chr8:91184101-91184102 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs78088467 | chr8:91184116-91184117 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs73306300 | chr8:91184123-91184124 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
18 | rs188310979 | chr8:91184129-91184130 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs539838883 | chr8:91184137-91184138 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs551759392 | chr8:91184173-91184174 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs566887743 | chr8:91184183-91184184 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs137898953 | chr8:91184233-91184234 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs555859950 | chr8:91184307-91184308 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs149055400 | chr8:91184313-91184314 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs538474473 | chr8:91184347-91184348 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs556578183 | chr8:91184351-91184352 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs374941609 | chr8:91184384-91184385 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs577872888 | chr8:91184385-91184386 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs545302042 | chr8:91184409-91184410 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs559682809 | chr8:91184428-91184429 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs549800354 | chr8:91184445-91184446 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs557996068 | chr8:91184488-91184489 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs561071767 | chr8:91184571-91184572 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs531395462 | chr8:91184582-91184583 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs549994509 | chr8:91184632-91184633 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs565076588 | chr8:91184675-91184676 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs532413953 | chr8:91184714-91184715 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs547735976 | chr8:91184763-91184764 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs73307904 | chr8:91184764-91184765 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
40 | rs534234191 | chr8:91184818-91184819 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs116347751 | chr8:91184866-91184867 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs2974995 | chr8:91184867-91184868 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
43 | rs537958881 | chr8:91184896-91184897 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs181014737 | chr8:91184897-91184898 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs183763815 | chr8:91184979-91184980 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs189700632 | chr8:91184995-91184996 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs143088161 | chr8:91185014-91185015 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs577880379 | chr8:91185125-91185126 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs554069737 | chr8:91185158-91185159 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs181235288 | chr8:91185200-91185201 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Wilms tumour | 21544195 | CNVD |
Gastric cancer | 17908304 | CNVD |
Melanoma | 18172304 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Autism | 19415332 | CNVD |
Malaria | 21533027 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Breast cancer | 21245420 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Liver carcinoma | 19366792 | CNVD |
Seminomas | 18059402 | CNVD |
Autism | 22495311 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Pancreatic cancer | 21811587 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Breast cancer | 17603634 | CNVD |
Testicular cancer | 18059402 | CNVD |
Breast cancer | 17133270 | CNVD |
Breast cancer | 21509527 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Breast cancer | 21858162 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Acute lymphoblastic leukemia | 21248843 | CNVD |
Cancer | 20164919 | CNVD |
Esophageal cancer | 20955586 | CNVD |
Multiple myeloma | 16461302 | CNVD |
abnormal development | 18461090 | CNVD |
Oral cancer | 21386901 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Langer-Giedion syndrome | 22283845 | CNVD |
Cancer | 21637783 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Breast cancer | 20632083 | CNVD |
Breast cancer | 19602461 | CNVD |
Cancer | 22429812 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Oral cancer | 19627613 | CNVD |
Prostate cancer | 21088497 | CNVD |
colon cancer | 17210682 | CNVD |
Breast cancer | 21264507 | CNVD |
Breast cancer | 22028636 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Cancer | 16751803 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Gastric cancer | 17167181 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Breast cancer | 16461572 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Medulloblastoma | 16968546 | CNVD |
head and neck squamous cell carcinoma | 18028549 | CNVD |
Breast cancer | 17001317 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Lung cancer | 18438408 | CNVD |
Breast cancer | 16608533 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Hepatocellular carcinoma | 18803288 | CNVD |
Prostate cancer | 18632612 | CNVD |
Glioblastoma multiforme | 18628472 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Prostate cancer | 16573809 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Cancer | 21949371 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Acute myeloid leukemia | 21358987 | CNVD |
Carcinoma ex pleomorphic adenoma | 18828159 | CNVD |
Adenocarcinoma | 21044232 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Prostate cancer | 16461572 | CNVD |
Breast cancer | 21399628 | CNVD |
Acute lymphoblastic leukemia | 18458336 | CNVD |
small cell lung cancer | 20016488 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Breast cancer | 17393978 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Non-syndromic sensorineural hearing loss | 20606397 | CNVD |
Bladder cancer | 19088036 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Breast cancer | 17899364 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Epilepsy | 20502679 | CNVD |
Breast cancer | 20409316 | CNVD |
Acute myeloid leukemia | 19651601 | CNVD |
head and neck squamous cell carcinoma | 19451471 | CNVD |
Renal cell carcinoma | 18765545 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Cutaneous T-cell lymphoma | 21881587 | CNVD |
Breast cancer | 21611746 | CNVD |
Breast cancer | 21364760 | CNVD |
Non-syndromic sensorineural hearing loss | 17122850 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr8:91177000-91187000 | Weak transcription | H9 Cell Line | embryonic stem cell |
2 | chr8:91183600-91185000 | Enhancers | K562 | blood |
3 | chr8:91184200-91184600 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
4 | chr8:91185000-91186800 | Weak transcription | K562 | blood |